Aesthetic device company Syneron Candela has launched a bipolar radiofrequency-needling system to the UK market.
The Profound device produces temperature-controlled radiofrequency, aimed at delivering energy to the deep dermis to stimulate neo-elastogenesis, neocollagenesis and hyaluronic acid deposition. It aims to treat skin laxity and improve skin quality in just one treatment and results can be seen between two to three weeks post treatment.
"With Profound, physicians deliver maximum results with minimum downtime, empowering the creation of younger, smoother skin with unprecedented outcomes," said Amit Meridor, chief executive officer of Syneron Candela. "We are delighted to receive recognition from the leading experts at Yahoo! and Plastic Surgery Practice, and honoured to be featured among treatments that revolutionise the way we combat ageing.